Literature DB >> 20063944

Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.

Shawn M McClintock1, Mustafa M Husain, Tracy L Greer, C Munro Cullum.   

Abstract

The effects of major depressive disorder (MDD) on neurocognitive function remain poorly understood. Results from published studies vary widely in terms of methodological factors, and very little is known about the effects of depression severity and other clinical characteristics on neurocognitive function. The purpose of this review was to synthesize prior research findings regarding neurocognitive functioning in patients with MDD and varying levels of depression severity and to provide recommendations for future directions. Overall, this review suggests that MDD has been inconsistently associated with neurocognitive functioning and there is limited understanding regarding the relationship between depression severity and neurocognitive sequelae. There was much heterogeneity on depression severity-related factors across studies assessing neurocognitive function in MDD, as well as substantial variability in the consideration of depression severity among studies, which suggests a need to further explore this important issue. Copyright 2009 APA, all rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20063944     DOI: 10.1037/a0017336

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  95 in total

1.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

Review 2.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

3.  Face emotion processing in depressed children and adolescents with and without comorbid conduct disorder.

Authors:  Karen Schepman; Eric Taylor; Stephan Collishaw; Eric Fombonne
Journal:  J Abnorm Child Psychol       Date:  2012-05

4.  Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.

Authors:  Brenda E Benson; Mark W Willis; Terence A Ketter; Andrew Speer; Tim A Kimbrell; Peter Herscovitch; Mark S George; Robert M Post
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

5.  Test-retest & familial concordance of MDD symptoms.

Authors:  Ariela J E Kaiser; Carter J Funkhouser; Vijay A Mittal; Sebastian Walther; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2020-07-20       Impact factor: 3.222

6.  Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.

Authors:  Matthew J Worley; Susan R Tate; Eric Granholm; Sandra A Brown
Journal:  J Consult Clin Psychol       Date:  2014-03-03

7.  An "alternating instructions" version of the Autobiographical Memory Test for assessing autobiographical memory specificity in non-clinical populations.

Authors:  Barbara Dritschel; Stamatis Beltsos; Shawn M McClintock; Stamatis Beltosis
Journal:  Memory       Date:  2013-11-12

8.  Preliminary analysis of age of illness onset effects on symptom profiles in major depressive disorder.

Authors:  Rebecca A Charlton; Melissa Lamar; Olusola Ajilore; Anand Kumar
Journal:  Int J Geriatr Psychiatry       Date:  2013-02-19       Impact factor: 3.485

Review 9.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

10.  Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress.

Authors:  J Bohacek; M Farinelli; O Mirante; G Steiner; K Gapp; G Coiret; M Ebeling; G Durán-Pacheco; A L Iniguez; F Manuella; J-L Moreau; I M Mansuy
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.